Concepedia

Mónica Nave

MN

4

Publications

799

Citations

4

H-Index

2007

Active since

Affiliations

Ulsan College(Current)

Asan Medical Center

University of Ulsan

Mónica Nave is an author at Ulsan College specializing in breast cancer, radiation oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2007–2022

4

Publications

4

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 404 citations · Full text

, , +7

Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: The DEBBRAH trial

José Manuel Pérez-García, Marta Vaz Batista, Patricia Cortez et al. · Neuro-Oncology · 2022 · 237 citations · Full text

Screening for a <i>BRCA2</i> Rearrangement in High-Risk Breast/Ovarian Cancer Families: Evidence for a Founder Effect and Analysis of the Associated Phenotypes

Patrícia Maria Abreu Machado, Rita D. Brandão, Branca Cavaco et al. · Journal of Clinical Oncology · 2007 · 112 citations · Full text

Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

Joseph Gligorov, Beyhan Ataseven, Mark Verrill et al. · European Journal of Cancer · 2017 · 46 citations

, , +7

Rows per page

1–4 of 4